OPTI:Optibiotix was the only share that dropped by 5% or more, falling 7%. It could have been a whole lot worse if there hadn't been a rally in the lead up to the trading update. How can a company so poorly manage its comms that a 100%+ increase in revenues is regarded as really bad news. The problem was, shareholders were expecting a 200% increase in revenue from all the comments made over the last 12 months. A lot of long term holders have either baled out completely or sold a significant proportion of their shares. I haven't sold a single share because I still believe this is a long term winner. There is a lot of news in the pipeline so hopefully this is a temporary setback.
DDDD:4D Pharma climbed 15% this week, which is great as a lot of that came after I bought some more. I decided to top slice a few JLP:Jubilee Metals after the recent run and sold 10,000 of my 100,000 for 14.605p after buying them for 4.3p. That gave me £1,018.15 (230.1%) profit and liberated £1,448.55. I used that to buy 1,133 DDDD shares at 128.625p costing £1,469.27. Happy to say they climbed to 147p, and when added to my existing 1,637 shares are in potential profit of £379 (10%). My SIPP holding is up 15% and making £479 potential profit, and my trading holding is up 8% making £39 potential profit. At least one of my bacteria company's share price knows how to behave.
CAML:Central Asia Metals zoomed up 16% on the back of base metal price rises and is now 44% up and making £4,290 potential profit. I'm expecting these to get to 340p in short order now they have momentum.
FXPO:Ferrexpo also took advantage of the increasing metals prices to climb 17% and go a spectacular 93% up making £947 potential profit as well as the £101 dividend. I've made a decision about my 12 month review of the magic formula shares. I'm going to sell enough to liberate £1,000 so I can buy a magic formula share higher up the ranking list, but keep the rest as "free" shares for the dividend. I'll only sell the rest if I decide I don't like them any more.
TRX:Tissue Regenix climbed 18% this week, although it's a slightly artificial rise as I bought some more. If Neil Woodford sets up his new fund, then there's no doubt in my mind he will come back to TRX, especially at these crazy low prices. I sold 300 of my CAML:Central Asia Metals shares for 254.21p making £188.79 (35.7%) profit and liberating £750.69. That was enough to buy 87,047 shares in TRX at 0.8566p costing £757.59. Unfortunately they dropped afterwards, but by reducing my weighted average to 1.6p and thanks to a rise early in the week, I ended up 18% higher. Given my first three purchases were 19.4p, 18.2p and 18.4p, it's great that buying a large number at 0.54p and 0.85p has lowered the average so much. The way things are going, I think they could get back to 18p.
Share of the Week is easy, as JLP:Jubilee Metals went utterly berserk and climbed 74%. There seems no stopping it at the moment. My holding is now up by 268% and despite taking £1,000 profit my remaining shares are making £10,412 potential profit. I'm a bit sad I no longer have 100,000, but there were two very important advantages of sacrificing 10,000. One was the DDDD:4D Pharma purchase just in time for them to hopefully significantly re-rate, and the other was to make enough profit to be able to write off one of my most toxic shares BLCC:Block Commodities. I was able to subsume the £707.98 loss without impacting my overall performance and I never have to report on the horrid thing again!
So close to the red line!
Just about staying above the trend line
Here's the ISA and shares portfolio after week 29 of year 6
| Weekly Change | |||
| Cash | £70.69 |
-£20.72 | |
| Portfolio cost | £63,391.43 | +£330.89 | |
| Portfolio sell value (bid price-commission) | £59,653.12 | (-5.9%) | +£254.94 |
| Potential profits | £10,791.92 | +£2,419.87 | |
| Yr 6 Dividends | £0 | +£0 | |
| Yr 6 Profit from sales | £1,015.43 | +£310.17 | |
| Yr 6 projected avg monthly profit | £147.81 | (4.2%) | +£42.72 |
| Total Dividends | £1,343.15 | +£0 | |
| Total Profit from sales | £21,442.04 | +£310.17 | |
| Average monthly cash profit | £337.76 | (9.7%) | +£3.49 |
|
(Sold stocks profit + Dividends - Fees / Months) |
|||
| Compound performance | 54% | +1% |
Only £310 increase in profits after writing off BLCC:Block Commodities £707 loss, as lets face it, they are never coming back. I was duped into their story when they were AFPO:African Potash, until it became clear the whole thing was an utter disaster, meandering from potash to blockchain to marihuana with never the remotest hope of delivering returns to shareholders. It feels great to have got rid of them, despite the fact they are still lurking worthlessly in my account.
With 6 months to go, year 6 is looking a bit poor, but I can get away with this sort of performance as my long term is at 9.7%. Ideally I need another £5k profits in order to get the annual performance to 10%. I'm hoping that will come when I sell my small OPTI:Optibiotix holding in the share account and use it to double the size of my trading account. I just need OPTI to get to 84p which it's trying its best to avoid doing.
Calm before the storm, but will it be nice or nasty?
Above the trend line is satisfactory
The SIPP looks like this after week 273 overall and week 13 of year 6.
| Weekly Change | ||||
| Cash | £227.20 | -£7.26 | ||
| Portfolio cost | £64,095.12 | +£207.65 | ||
|
Portfolio sell value (bid price - commission) |
£61,291.71 | (-4.4%) | -£362.25 | |
| Potential profits | £6,952.99 | +£1,993.21 | ||
| Yr 6 Dividends | £419.17 | +£0 | ||
| Yr 6 Interest | £0 | +£0 | ||
| Yr 6 Profit from sales | £2,564.14 | +£188.79 | ||
| Yr 6 projected avg monthly profit | £977.66 | (29.3%) | -£13.42 | |
| Total Dividends | £2,486.25 | +£0 | ||
| Total Interest | £0.20 | +£0 | ||
| Total Profit from sales | £18,023.58 | +£188.79 | ||
| Average monthly cash profit | £314.90 | (9.4%) | +£1.84 | |
|
(Sold stocks profit + Dividends - Fees / Months) |
||||
| Compound performance | 49% | +0% |
The big rise in profits wasn't quite enough to make up for the OPTI:Optibiotix fall, so value dropped a little and long term average was maintained rather then improving very much.
All the charts are looking the same - I think I need to stop buying the same shares in each account!
It's not often the SIPP is performing worse than the ISA, but it's a lot closer to going below the trend line.
The trading account looks like this after week 239 overall and week 31 of year 5
| Weekly Change | |||
| Cash | £249.58 | +£0 | |
| Portfolio cost | £2,364.43 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,980.08 | (-16.3%) | +£114.49 |
| Potential profits | £68.52 | +£68.52 | |
| Year 5 Dividends | £12.18 | +£0 | |
| Year 5 Profit | £631.65 | +£0 | |
| Yr 5 projected avg monthly profit | £90.00 | (45.7%) | -£3.20 |
| Dividends | £60.10 | +£0 | |
| Profit from sales | £918.02 | +£0 | |
| Average monthly cash profit | £17.73 | (9.0%) | -£0.08 |
|
(Sold stocks profit + Dividends - Fees / Months) |
Great rise and both CAML:Central Asia Metals and DDDD:4D Pharma have gone into profit. I'll be watching those closely next week with a view to selling. I so badly want to get the £2,500 from selling the OPTI:Optibiotix shares in here as I reckon if I had 10 shares to pick from I've be able to sell at least one a week.
Back towards the recent highs.
Back above the trend line.
I'm trying to decide how I feel about top slicing some of my favourite shares this week. I do feel bad about having less of them than I did before, but when a great opportunity comes along you need to have cash, and I don't have any cash reserves so selling something is the only option. I think it's also good for the morale to bank a little profit now and again, as long as it doesn't impact the long term value of the holding too much.
I was really in two minds about selling 10% of my JLP:Jubilee Metals holding, especially as I'd already sold 42k at the crazy low price of 6.4p for just £835 profit when I could have made £4,293 if I'd held a few more weeks. I wanted more DDDD:4D Pharma before their Nasdaq launch but I wasn't convinced it was a good idea. It was definitely the chance to write off BLCC:Block Commodities that swung it for me, so I think if you have a good enough reason it's ok to sacrifice long term gains. I may not think so when they get to 40p and I look at the £2,500 extra I would have got, but by then DDDD might be £5 a share.
It's almost a year since the big Covid crash, when I really began to think my portfolio was utterly doomed. Those days when it was worth much less than I'd put in were absolutely horrible, when I think about the sacrifices I made to pay off the loans I used to kick start the portfolio. I still have knackered soffits and a hole on my bay window roof because I'm paying back the loans on buying shares and going to Ecuador, although in fairness a lot of that was down to Ecuador! At least now the portfolio is almost back in the black and justifying investing here instead of the building society.
No comments:
Post a Comment